Here, the expressing condition of ZNF667-AS1 in 155 glioma patients was first examined, confirming that the ZNF667-AS1 expression was distinctly upregulated in glioma specimens in comparison with matched nontumor brain tissues, which was inconsistent with its expression trend in other several tumors. This evidence concerns the gene ZNF667 and glioma.